Indications
The relief of symptoms associated with allergic rhinitis and urticaria.
Contraindications
Known hypersensitivity to desloratadine, loratadine, or any ingredient in the formulation.
Compositon/Ingredients
Desloratadin 5mg
Dosage and administration
Adults and adolescents (12 years of age and over): 1 tablet once a day.
Intermittent allergic rhinitis (presence symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient’s disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.
In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure period.
Precaution
The safety and efficacy of Neoloridin 5mg in children below the age of 12 years have not been established.
In the case of severe renal insufficiency, desloratadine should be used with caution.
The use of Neoloridin 5mg during pregnancy in breastfeeding women is not recommended.
Patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. Patients should be aware of how they react to drug before driving or operating machinery.
Storage
Store at temperature below 30°C, protect from light.
